Dr. Marc Norman Berliant, MD

Dr. Berliant practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. Berliant's NPI, 1154324317, was assigned on May 23, 2005. Dr. Berliant graduated from University of Illinois College of Medicine at Chicago in 1977. Dr. Berliant holds New York license 140442.

Dr. Berliant's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Dr. Berliant's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. Dr. Berliant is also affiliated with Highland Hospital. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Berliant to 1 more hospital, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berliant practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Berliant's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Berliant is board certified in internal medicine by the American Board of Internal Medicine. Dr. Berliant is licensed in New York.

CMS data shows 228 Medicare services from Dr. Berliant across 5 procedure codes in 2024, for 138 Medicare patients. Medicare paid $11,691 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 138 Medicare patients who saw Dr. Berliant in 2024. The largest group is under 65, with 52 patients. 75% of them have high blood pressure, and 62% have high cholesterol. 52% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Berliant's median patient age at 64, with 54% women.

In 2024, Dr. Berliant wrote 3,529 Medicare Part D claims for 363 patients. 87% of them were for generic drugs. CMS names the drug for 2,914 of them, across 82 drugs with 11 or more claims each, at $307,580 in total drug cost. In 2023, CMS named 2,153 claims across 64 drugs.

Dr. Berliant accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Berliant as offering telehealth.

Dmand AI links 5 papers to Dr. Berliant, published from 2019 to 2022. 2020 was the busiest year, with 2. The most frequent topics are Primary Health Care, Asthma and Electronic Health Records. Dr. Berliant's most frequent co-authors are Amber Crowley, MD, Jill S. Halterman, MD and Jennifer Sophie Mammen, MD.

Dmand AI links Dr. Berliant to 1 clinical trial. Conditions studied include Asthma and Respiratory Hypersensitivity.

Dr. Berliant graduated from University of Illinois College of Medicine at Chicago in 1977.